EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serpin A1 Cargo Within Tumour‐Derived Extracellular Vesicles Supports Pro‐Tumoural Bias of Neutrophils in Cancer

Maksim Domnich iD, Ekaterina Pylaeva iD, Elena Siakaeva iD, Nastassia Kabankova, Agnieszka Bedzinska, Damian Sojka, Aneta Zebrowska iD, Marta Gawin iD, Maren Soldierer iD, Yaping Yu, Malwina Rist, Daniel Fochtman iD und 11 weitere

Journal of Extracellular Vesicles · 2026-11 · 15 (11)

DOI: 10.1002/jev2.70385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 02.11.2026. Verfasst von Maksim Domnich und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Neutrophils, Extracellular Vesicles, Plasminogen Activator Inhibitor 1, Head and Neck Neoplasms. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRC TRR332 project A05, Programm zur internen Forschungsförderung Essen (IFORES), Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumour‐derived extracellular vesicles (EVs) or exosomes are critical mediators of the cancer‐immune system crosstalk, yet the mechanisms by which they reprogram neutrophil function in vivo remain insufficiently characterised. Here, we identify the serine protease inhibitor Serpin A1 as a predominant cargo component of small EVs (sEVs) released by head and neck cancer cels (HNC) and show that this molecule is both necessary and sufficient to confer a stable pro‐tumoural programming of neutrophils. Uptake of Serpin A1‐enriched sEVs elicits extensive proteomic remodelling in neutrophils including activation of STAT3 signalling, leading to sustained induction of PD‐L1, increased Arginase 1 production and prolonged neutrophil lifespan. Functionally, these reprogrammed neutrophils acquire a capacity to drive epithelial‐mesenchymal transition in tumour cells, and to impose exhaustion of T cells via metabolic restriction and arginine depletion, leading to their reduced cytotoxicity. Genetic ablation of Serpin A1 from tumour‐derived sEVs or pharmacologic inhibition of serpin‐STAT3 axis restores neutrophil anti‐tumour functions. Collectively, these findings delineate a Serpin A1‐STAT3/Arginase 1 as an important signalling pathway through which tumour‐derived sEVs promote neutrophil‐dependent immune suppression and tumour progression, and highlight EV‐associated serpins as potential targets for future therapeutic intervention in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsExtracellular VesiclesPlasminogen Activator Inhibitor 1Head and Neck NeoplasmsHumansAnimalsSTAT3 Transcription FactorMiceSignal TransductionEpithelial-Mesenchymal TransitionArginase

Stichwörter der Autor:innen

STAT3arginase 1epithelial‐to‐mesenchymal transition (EMT)exosomeshead and neck cancer (HNC)immunosuppressionneutrophilsproteomeserpin A1small extracellular vesicles (sEVs)

Substanzen

STAT3 Transcription FactorPlasminogen Activator Inhibitor 1Arginase

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Dermatology and Allergy, LMU Hospital, Ludwig-Maximilians-University, Munich, Germany.
  • German Cancer Consortium (DKTK) Partner Site Düsseldorf/Essen, Essen, Germany.
  • Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
  • Department of Pediatrics III, University Children's Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
  • German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

ORCID-Profile: Maksim Domnich, Ekaterina Pylaeva, Elena Siakaeva, Aneta Zebrowska, Marta Gawin, Maren Soldierer, Daniel Fochtman, Bernd Giebel, Iris Helfrich, Basant Kumar Thakur, Cornelius H L Kürten, Sonja Ludwig, Piotr Widlak, Stephan Lang, Monika Pietrowska, Jadwiga Jablonska

Förderung

  • CRC TRR332 project A05
  • Programm zur internen Forschungsförderung Essen (IFORES)
  • Deutsche Forschungsgemeinschaft
  • Narodowa Agencja Wymiany Akademickiej

Zitieren

APA

Domnich, M., Pylaeva, E., Siakaeva, E., Kabankova, N., Bedzinska, A., Sojka, D., Zebrowska, A., Gawin, M., Soldierer, M., Yu, Y., Rist, M., Fochtman, D., Giebel, B., Helfrich, I., Thiel, I., Thakur, B. K., Kürten, C. H. L., Hanenberg, H., Ludwig, S., …, & Jablonska, J. (2026). Serpin A1 Cargo Within Tumour‐Derived Extracellular Vesicles Supports Pro‐Tumoural Bias of Neutrophils in Cancer. Journal of Extracellular Vesicles, 15(11). https://doi.org/10.1002/jev2.70385

Vancouver

Domnich M, Pylaeva E, Siakaeva E, Kabankova N, Bedzinska A, Sojka D, et al. Serpin A1 Cargo Within Tumour‐Derived Extracellular Vesicles Supports Pro‐Tumoural Bias of Neutrophils in Cancer. Journal of Extracellular Vesicles. 2026;15(11). doi:10.1002/jev2.70385

BibTeX
@article{Domnich2026,
  author = {Domnich, Maksim and Pylaeva, Ekaterina and Siakaeva, Elena and Kabankova, Nastassia and Bedzinska, Agnieszka and Sojka, Damian and Zebrowska, Aneta and Gawin, Marta and Soldierer, Maren and Yu, Yaping and Rist, Malwina and Fochtman, Daniel and Giebel, Bernd and Helfrich, Iris and Thiel, Ilona and Thakur, Basant Kumar and Kürten, Cornelius H L and Hanenberg, Helmut and Ludwig, Sonja and Widlak, Piotr and Lang, Stephan and Pietrowska, Monika and Jablonska, Jadwiga},
  title = {Serpin A1 Cargo Within Tumour‐Derived Extracellular Vesicles Supports Pro‐Tumoural Bias of Neutrophils in Cancer},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/jev2.70385}
}
Kostenlos starten →